Patents by Inventor Robert Melder

Robert Melder has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Vascular endothelial growth factor-2
    Publication number: 20050181979
    Abstract: The present invention is directed to VEGF-2 polynucleotides and polypeptides and methods of using such polynucleotides and polypeptides. In particular, provided are methods of treating retinal disorders with VEGF-2 polynucleotides and polypeptides.
    Type: Application
    Filed: March 14, 2005
    Publication date: August 18, 2005
    Applicant: Human Genome Sciences, Inc.
    Inventors: Ralph Alderson, Robert Melder, Viktor Roschke, Steven Ruben, Craig Rosen
  • Fibroblast Growth Factor-13
    Publication number: 20050026838
    Abstract: The present invention relates to a novel human protein called Fibroblast Growth Factor 13, and isolated polynucleotides encoding this protein. Also provided are vectors, host cells, antibodies, and recombinant methods for producing this human protein. The invention further relates to diagnostic and therapeutic methods useful for diagnosing and treating disorders related to this novel human protein.
    Type: Application
    Filed: September 2, 2004
    Publication date: February 3, 2005
    Applicant: Human Genome Sciences, Inc.
    Inventors: John Greene, Joachim Gruber, Craig Rosen, Ralph Alderson, Robert Melder, D. Duan
  • Fibroblast Growth Factor-10
    Publication number: 20050019824
    Abstract: The present invention relates to a novel human protein called Fibroblast Growth Factor 10, and isolated polynucleotides encoding this protein. Also provided are vectors, host cells, antibodies, and recombinant methods for producing this human protein. The invention further relates to diagnostic and therapeutic methods useful for diagnosing and treating disorders related to this novel human protein.
    Type: Application
    Filed: September 8, 2004
    Publication date: January 27, 2005
    Applicants: Human Genome Sciences, Inc., The Institute for Genomic Research
    Inventors: Ralph Alderson, Robert Melder, D. Duan, Craig Rosen, Jing-Shan Hu, Jeannine Gocayne
  • Fibroblast growth factor-14
    Publication number: 20040043024
    Abstract: The present invention relates to a novel human protein called Fibroblast Growth Factor 14, and isolated polynucleotides encoding this protein. Also provided are vectors, host cells, antibodies, and recombinant methods for producing this human protein. The invention further relates to diagnostic and therapeutic methods useful for diagnosing and treating disorders related to this novel human protein.
    Type: Application
    Filed: September 16, 2003
    Publication date: March 4, 2004
    Applicant: Human Genome Sciences, Inc.
    Inventors: Ralph Alderson, Robert Melder, D. Roxanne Duan, John M. Greene, Patrick J. Dillon